Drug pricing reform deal may allow Medicare to negotiate with drug firms for first time
By
Alicia Lasek
Nov 04, 2021
The Democrats’ deal also would limit insulin costs and cap annual out-of-pocket spending at $2,000 for seniors. Pharmacy benefit managers would face transparency requirements as well.
Cannabis-related issues sending more seniors to the ED, study finds
By
Alicia Lasek
Jan 12, 2023
Cannabis-related ED visits for older adults shot up by a whopping 1,800% between 2005 to 2019 in California, investigators say. The state’s experience mirrors national trends.